HERA medical countermeasures for CBRN threats – Detection and diagnosis
Funds R&D on rapid tests that detect chemical and biological agents, including biotoxins.
HaDEA runs this topic to raise the EU's preparedness against chemical, biological, radiological and nuclear threats by funding detection and diagnostic tests that can rapidly identify a single agent or a broad range of chemical and biological agents, including biotoxins. It funds work across an end-to-end path from advanced research and development, through involving end users and security practit…
This topic funds development of detection and diagnostic tests as medical countermeasures against CBRN threats, with a special focus on tests that can rapidly detect a single agent or a broad range of chemical and biological agents, including biotoxins. It's part of the same HERA effort as the medicinal-products and PPE topics, aimed at bridging the gap between research and market-ready detection tools.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Find grantsGovernment Grants for Startups: What Deeptech Founders Should Know
A practical guide to government grants for startups, including Grants.gov, SBIR/STTR, state programs, eligibility, fit, timelines, and when to apply.
Start hereTRL Levels Explained for Deeptech Founders
Learn what TRL levels mean, how to estimate technology readiness, and how TRL affects grants, EIC Accelerator, SBIR/STTR, funding stage, and application evidence.
More from HaDEA
All grants from this funder →AI and Health-Data Flagship for Cardiovascular and Related Disease Care
🇪🇺HaDEA · European Union
Funds a flagship project that federates EU health data and pilots AI tools for cardiovascular risk prediction, prevention and personalised care.
Cancer screening programmes for gastric cancer
🇪🇺HaDEA · European Union
Funds a stepwise rollout of gastric cancer screening programmes across EU Member States, including AI-assisted screening.
Coordinated access to European spaceports
🇪🇺HaDEA · European Union
Funds a study that proposes common rules and best practices so European launch providers can access any European spaceport more easily.
Digital enablers and building blocks for autonomous space transportation systems
🇪🇺HaDEA · European Union
Funds early-stage digital technology — health monitoring, smart avionics, AI data processing — that makes future launch systems more autonomous.
Digital solutions for space transportation autonomy — targeting demonstration
🇪🇺HaDEA · European Union
Funds on-ground or in-orbit demonstration of structural-damage detection and thermo-mechanical monitoring for reusable launch systems.
EU4Health Conferences and Events Grants
🇪🇺HaDEA · European Union
Funds not-for-profit, Union-wide conferences on EU health priorities that bring together policymakers, scientists and civil society.
Similar grants
Browse the directory →
Innovative healthcare interventions for non-communicable diseases
🇪🇺European Commission · European Union
Funds €7–8M projects that validate innovative interventions for cardiovascular, metabolic, respiratory or kidney disease.
Clinical trials for advancing innovative interventions for neurodegenerative diseases
🇪🇺European Commission · European Union
Funds early clinical trials of safer, more effective interventions for non-rare neurodegenerative diseases.
Cancer Mission: Functional Genomics for New Treatments
🇪🇺European Commission · European Union
Funds €7–8M projects that use functional genomics and patient data to uncover precise new targets for difficult-to-treat cancers.
Horizon Health: Antibody Therapies for Emerging Viruses
🇪🇺European Commission · European Union
Funds €9–10M projects that turn monoclonal antibodies into prevention and treatment options for one emerging virus.
Horizon Cancer Mission: Microbiome Early Detection
🇪🇺European Commission · European Union
Funds a €15M project that turns microbiome signals into a test for spotting cancer risk years ahead of any symptoms.
Challenge Programme — AMR Diagnostics for LRTI
🇩🇰NNF · Denmark
Supports diagnostic innovations for antimicrobial resistant respiratory infections in Danish consortia.